SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural
Capital flows are healthy (fund flow score 7.69/10), with Small and Large inflows slightly positive despite an overall negative trend. Among analysts, 50% Strong Buy and 50% Buy ratings create a bullish consensus, though historical win rates vary (25% for Citizens, 42.9% for HC Wainwright). Sentiment is neutral, but liquidity support and analyst optimism offset some downside risks.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionHC Wainwright & Co.
Times predicted7
Historical Win Rate42.9%
Is money flowing into or out of SMMT?
- SMMT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).
